In this knowledge-based continuing pharmacy education activity Trinh Pham, PharmD, BCOP discusses pharmacogenomics in current practice.
Pharmacists interested in pharmacogenomics.
This activity is not accredited for technicians
At the conclusion of the activity, pharmacists will be able to:
- Review the concept of pharmacogenetics and pharmacogenomics
- Discuss how genetics affect the activity of drug metabolizing enzymes
- Discuss examples of how pharmacogenetics and pharmacogenomics will lead to individualization of drug therapy
- Identify resources for obtaining current and updated pharmacogenomics information
Trinh Pham, Pharm.D., BCOP
Associate Clinical Professor
UConn School of Pharmacy
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
Trinh Pham, PharmD, BCOP has no actual or potential conflicts of interest associated with this presentation.
Click on the registration link to register for this activity. The cost is $15.00.
This activity has no grant funding associated with it.
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hour (0.1 CEU) will be awarded to pharmacists who view the presentation, pass the learning assessment with a grade of 70% or better and complete an evaluation. (ACPE #0009-0000-17-090-H04-P) Credits will be electronically submitted to CPE Monitor within 72 hours of completing the activity.
Initial release date: December 15, 2017
Planned expiration date: December 15, 2020
The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.